Enanta Pharmaceuticals
ENTA
#7977
Rank
HK$2.91 B
Marketcap
HK$100.21
Share price
-1.31%
Change (1 day)
58.99%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -HK$0.41 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are HK$69.21 Million. In 2025 the company made an earning of -HK$0.51 Billion, an increase over its 2024 earnings that were of -HK$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.41 Billion-19.77%
2025 -HK$0.51 Billion-34.07%
2024 -HK$0.77 Billion-23.87%
2023 -HK$1 Billion4.39%
2022 -HK$0.96 Billion-4.4%
2021 -HK$1.01 Billion91.12%
2020 -HK$0.53 Billion-407.13%
2019 HK$0.17 B-78.63%
2018 HK$0.79 B117.97%
2017 HK$0.36 B-574.65%
2016 -HK$77.16 Million-110.83%
2015 HK$0.71 B-4.5%
2014 HK$0.74 B-638.53%
2013 -HK$0.14 Billion-137.98%
2012 HK$0.36 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.70 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$123.76 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
HK$46.85 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$39.69 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$103.12 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$75.25 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA